Target intelligence / Profile preview

Mago homolog, exon junction complex subunit (MAGOH)

Target
MAGOH
Molecular classification
Other (core component of the exon junction complex; not an enzyme, receptor, transporter, ion channel, or transcription factor)
01

Overview

MAGOH is a highly conserved, small protein that forms the core of the exon junction complex (EJC), a multiprotein assembly deposited on mature mRNA approximately 20 nucleotides upstream of exon-exon junctions following splicing[1][3][5]. It tightly binds to Y14 (RBM8A) and interacts with the mRNA export factor TAP, but not with other EJC components directly[3][5]. MAGOH is essential for post-splicing mRNA processing, including nuclear export, cytoplasmic localization, and particularly nonsense-mediated mRNA decay. It remains associated with mRNA after export from the nucleus[3][5]. In model organisms, loss of magoh results in severe developmental defects and embryonic lethality, underlining its fundamental importance[3]. In humans, MAGOH is not considered a traditional therapeutic target (such as a receptor or enzyme), but is vital for cellular RNA metabolism. No small-molecule drugs are known to modulate its activity.

Other names
Protein mago nashi homologMAGOHAMAGOH1mago-nashi homologmago homologexon junction complex core componentproliferation-associated protein MAGOH
02

Mechanism of action

MAGOH is not directly targeted by drugs; its function is structural and regulatory within the exon junction complex[2][3]

03

Biological functions

mRNA splicingmRNA nuclear exportregulation of nonsense-mediated mRNA decaypost-splicing mRNA processingmRNA localization
04

Disease associations

Other (essential for viability; mutations are lethal in model organisms; implicated in germline and axis specification in Drosophila; depletion affects mRNA quality control, potentially relevant in developmental disorders or cancer via mRNA metabolism dysregulation[3][1][6])

Beyond the preview

Go deeper on Mago homolog, exon junction complex subunit (MAGOH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mago homolog, exon junction complex subunit (MAGOH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call